Breaking news in our fight against Covid-19
Our next-generation recombinant protein adjuvanted vaccine has been approved by the EMA for use in Europe.
Third Quarter 2022 Results
FINANCIAL RESULTS | October 28, 2022
Third quarter 2022 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Ending the Neglect of Sleeping Sickness
We continue our international efforts to eliminate this disease.
Our Latest News
Evolve With Us
At Sanofi, we offer many benefits, including parental leave, to enrich your life and empower you to grow, and create your own life journey
Our response to the situation in Ukraine
Information and updates on how our company is responding as the situation in Ukraine evolves
Our Integrated Report 2021
We chase the miracles of science to improve people’s lives and to transform the practice of medicine